![](/img/cover-not-exists.png)
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular response
Ho-Young Yhim, Na-Ri Lee, Eun-Kee Song, Chang-Yeol Yim, So Yeon Jeon, Seunghwan Shin, Jeong-A Kim, Hee Sun Kim, Eun Hae Cho, Jae-Yong KwakVolume:
36
Year:
2012
Language:
english
Pages:
5
DOI:
10.1016/j.leukres.2012.02.011
File:
PDF, 270 KB
english, 2012